What have we learned about risk factors for local recurrence after breast-conserving surgery and irradiation?
JR Harris and R Gelman
JCO Apr 1 1994: 647–649. [PDF]
Did we focus on the most important issues in the use of growth factors and stem-cell transplantation?
SC Gulati
JCO Apr 1 1994: 650–652. [PDF]
	Risk factors in breast-conservation therapy
	J Borger, H Kemperman, A Hart, H Peterse, J van Dongen, and H Bartelink
	JCO Apr 1 1994: 653–660. [Abstract] [PDF]
	Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit
	G Spitzer, DR Adkins, V Spencer, FR Dunphy, PJ Petruska, WS Velasquez, CE Bowers, N Kronmueller, R Niemeyer, and W McIntyre
	JCO Apr 1 1994: 661–670. [Abstract] [PDF]
	Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor
	E Estey, P Thall, M Andreeff, M Beran, H Kantarjian, S O'Brien, S Escudier, LE Robertson, C Koller, and S Kornblau
	JCO Apr 1 1994: 671–678. [Abstract] [PDF]
	Proliferating cell nuclear antigen and mitotic activity in rectal cancer: predictor of response to preoperative irradiation
	CG Willett, G Warland, R Cheek, J Coen, J Efird, PC Shellito, and CC Compton
	JCO Apr 1 1994: 679–682. [Abstract] [PDF]
	Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer
	A Sella, R Kilbourn, R Amato, C Bui, AA Zukiwski, J Ellerhorst, and CJ Logothetis
	JCO Apr 1 1994: 683–688. [Abstract] [PDF]
	Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer
	MJ Moore, D Osoba, K Murphy, IF Tannock, A Armitage, B Findlay, C Coppin, A Neville, P Venner, and J Wilson
	JCO Apr 1 1994: 689–694. [Abstract] [PDF]
	Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma
	JA Conti, N Kemeny, K Seiter, E Goker, W Tong, M Andre, K Ragusa, and JR Bertino
	JCO Apr 1 1994: 695–700. [Abstract] [PDF]
	Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group
	S Williams, JA Blessing, SY Liao, H Ball, and P Hanjani
	JCO Apr 1 1994: 701–706. [Abstract] [PDF]
	Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer
	S Vadhan-Raj, AP Kudelka, L Garrison, J Gano, CL Edwards, RS Freedman, and JJ Kavanagh
	JCO Apr 1 1994: 707–714. [Abstract] [PDF]
	Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma
	S Vadhan-Raj, NE Papadopoulos, MA Burgess, KA Linke, SR Patel, C Hays, A Arcenas, C Plager, AP Kudelka, and WN Hittelman
	JCO Apr 1 1994: 715–724. [Abstract] [PDF]
	Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction
	M Gerhard, H Juhl, H Kalthoff, HW Schreiber, C Wagener, and M Neumaier
	JCO Apr 1 1994: 725–729. [Abstract] [PDF]
	Tumor epidermal growth factor receptor studies in patients with non- small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852 [published erratum appears in J Clin Oncol 1994 Jul;12(7):1526]
	R Perez-Soler, NJ Donato, DM Shin, MG Rosenblum, HZ Zhang, C Tornos, H Brewer, JC Chan, JS Lee, and WK Hong
	JCO Apr 1 1994: 730–739. [Abstract] [PDF]
	Treatment of childhood acute lymphoblastic leukemia: results of Dana- Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01
	MA Schorin, S Blattner, RD Gelber, NJ Tarbell, M Donnelly, V Dalton, HJ Cohen, and SE Sallan
	JCO Apr 1 1994: 740–747. [Abstract] [PDF]
	Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results
	IF Khouri, MJ Keating, HM Vriesendorp, CL Reading, D Przepiorka, YO Huh, BS Andersson, KW van Besien, RC Mehra, and SA Giralt
	JCO Apr 1 1994: 748–758. [Abstract] [PDF]
	High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma
	D Cunningham, L Paz-Ares, S Milan, R Powles, M Nicolson, T Hickish, P Selby, J Treleavan, C Viner, and J Malpas
	JCO Apr 1 1994: 759–763. [Abstract] [PDF]
	High-dose melphalan for multiple myeloma: long-term follow-up data
	D Cunningham, L Paz-Ares, ME Gore, J Malpas, T Hickish, M Nicolson, M Meldrum, C Viner, S Milan, and PJ Selby
	JCO Apr 1 1994: 764–768. [Abstract] [PDF]
	Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group
	IA Cooper, MM Wolf, TI Robertson, RM Fox, JP Matthews, JM Stone, JC Ding, G Dart, J Matthews, and FC Firkin
	JCO Apr 1 1994: 769–778. [Abstract] [PDF]
	ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group
	MH Cullen, NS Stuart, C Woodroffe, A Murphy, J Fletcher, GR Blackledge, JA Child, RJ Grieve, and EL Jones
	JCO Apr 1 1994: 779–787. [Abstract] [PDF]
	2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma
	M Hoffman, MS Tallman, D Hakimian, D Janson, D Hogan, D Variakogis, T Kuzel, LI Gordon, and K Rai
	JCO Apr 1 1994: 788–792. [Abstract] [PDF]
	Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis
	G Nadali, F Vinante, A Ambrosetti, G Todeschini, D Veneri, R Zanotti, V Meneghini, MM Ricetti, F Benedetti, and A Vassanelli
	JCO Apr 1 1994: 793–797. [Abstract] [PDF]
	Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma
	PW Johnson, CG Price, T Smith, FE Cotter, J Meerabux, AZ Rohatiner, BD Young, and TA Lister
	JCO Apr 1 1994: 798–805. [Abstract] [PDF]
	Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma
	E Bajetta, A Di Leo, MG Zampino, MR Sertoli, G Comella, M Barduagni, B Giannotti, P Queirolo, G Tribbia, and MG Bernengo
	JCO Apr 1 1994: 806–811. [Abstract] [PDF]
	Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil
	SC Linn, CK van Kalken, O van Tellingen, P van der Valk, CJ van Groeningen, CM Kuiper, HM Pinedo, and G Giaccone
	JCO Apr 1 1994: 812–819. [Abstract] [PDF]
	Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation
	CA Meyers, M Weitzner, K Byrne, A Valentine, RE Champlin, and D Przepiorka
	JCO Apr 1 1994: 820–826. [Abstract] [PDF]
	Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients
	MR O'Donnell, GM Schmidt, BR Tegtmeier, C Faucett, JL Fahey, J Ito, A Nademanee, J Niland, P Parker, and EP Smith
	JCO Apr 1 1994: 827–834. [Abstract] [PDF]
	Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
	NL Bartlett, BL Lum, GA Fisher, NA Brophy, MN Ehsan, J Halsey, and BI Sikic
	JCO Apr 1 1994: 835–842. [Abstract] [PDF]
	Attitudes about genetic testing for breast-ovarian cancer susceptibility
	C Lerman, M Daly, A Masny, and A Balshem
	JCO Apr 1 1994: 843–850. [Abstract] [PDF]
	Cancer chemoprevention
	SM Lippman, SE Benner, and WK Hong
	JCO Apr 1 1994: 851–873. [Abstract] [PDF]
Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer
JM Bennett, AB Troxel, R Gelman, G Falkson, MD Coccia-Portugal, R Dreicer, DC Tormey, and D Rushing
JCO Apr 1 1994: 874–875. [PDF]
An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin
KH Yeh and AL Cheng
JCO Apr 1 1994: 875–876. [PDF]
Mantle cell lymphoma
NL Harris
JCO Apr 1 1994: 876–877. [PDF]
Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal
JP Pignon, M Ducreux, and P Rougier
JCO Apr 1 1994: 877–878. [PDF]
Meta-analyses need time, collaboration, and funding
P Piedbois and M Buyse
JCO Apr 1 1994: 878–880. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.